Global Cancer Registry Software Market By Software (Cross- Disciplinary and Specific), Type (Standalone and Integrated), Deployment Model (On- Premise and Cloud- Based), Database Type (Commercial and Public), Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research and Clinical Studies and Product Outcome Evaluation), End User (Government Organizations and Third-Party Administrators, Hospitals and Medical Practices, Private Payers, Pharmaceutical, Biotechnology and Medical Device Companies, Research Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028